CoChat

Accurate stratification between VEXAS syndrome and differential diagnoses by deep learning analysis of peripheral blood smears

Chabrun, Floris, Lacombe, Valentin, Dieu, Xavier, Geneviève, Franck, Urbanski, Geoffrey · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Objectives: VEXAS syndrome is a newly described autoinflammatory disease associated with UBA1 somatic mutations and vacuolization of myeloid precursors. This disease possesses an increasingly broad spectrum, leading to an increase in the number of suspected cases. Its diagnosis via bone-marrow aspiration and UBA1-gene sequencing is time-consuming and expensive. This study aimed at analyzing peripheral leukocytes using deep learning approaches to predict VEXAS syndrome in comparison to differential diagnoses. Methods: We compared leukocyte images from blood smears of three groups: participants with VEXAS syndrome (identified UBA1 mutation) (VEXAS); participants with features strongly suggestive of VEXAS syndrome but without UBA1 mutation (UBA1-WT); participants with a myelodysplastic syndrome and without clinical suspicion of VEXAS syndrome (MDS). To compare images of circulating leukocytes, we applied a two-step procedure. First, we used self-supervised contrastive learning to train convolutional neural networks to translate leukocyte images into lower-dimensional encodings. Then, we employed support vector machine to predict patients’ condition based on those leukocyte encodings. Results: The VEXAS, UBA1-WT, and MDS groups included 3, 3, and 6 patients respectively. Analysis of 33,757 images of neutrophils and monocytes enabled us to distinguish VEXAS patients from both UBA1-WT and MDS patients, with mean ROC-AUCs ranging from 0.87 to 0.95. Conclusions: Image analysis of blood smears via deep learning accurately distinguished neutrophils and monocytes drawn from patients with VEXAS syndrome from those of patients with similar clinical and/or biological features but without UBA1 mutation. Our findings offer a promising pathway to better screening for this disease.

Overview

Integrity signals

Registry

Crossref · 10.1515/cclm-2022-1283

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Cited by

See all 14

Metadata

Authors
Chabrun, F., Lacombe, V., Dieu, X., Geneviève, F., & Urbanski, G.
Affiliations
  • Centre National de la Recherche Scientifique (FR)
  • Centre Hospitalier Universitaire d'Angers (FR)
Corresponding author
Urbanski, Geoffrey
Venue
Clinical Chemistry and Laboratory Medicine (CCLM)
Published
2023-02-02
Volume
61
Issue
7
Pages
1275-1279
ISSN
  • 1434-6621 (ISSN-L)
  • 1437-4331
OpenAlex
W4318753853
Cited by
13
References
15
Citations by year
2025: 1 · 2024: 5 · 2023: 7
FWCI
1.18
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Chemistry and Laboratory Medicine (CCLM) (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Computer Science › Computer Vision and Pattern Recognition › Digital Imaging for Blood Diseases
  • Health Sciences › Medicine › Hematology › Hematological disorders and diagnostics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biophysics › Cell Image Analysis Techniques
Keywords
VEXAS syndrome, UBA1 mutation, peripheral blood smear, neutrophils, monocytes, myelodysplastic syndrome, autoinflammatory disease, differential diagnosis, disease screening, self-supervised contrastive learning, convolutional neural networks, support vector machine
MeSH terms
Deep Learning, Diagnosis, Differential, Humans, Leukocytes, Mutation, Myelodysplastic Syndromes, Skin Diseases, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Accurate stratification between VEXAS syndrome and differential diagnoses by deep learning analysis of peripheral blood smears. https://app.cochat.ai/papers/10.1515/cclm-2022-1283
The paper
Chabrun, F., Lacombe, V., Dieu, X., Geneviève, F., & Urbanski, G. (2023). Accurate stratification between VEXAS syndrome and differential diagnoses by deep learning analysis of peripheral blood smears. Clinical Chemistry and Laboratory Medicine (CCLM). https://doi.org/10.1515/cclm-2022-1283

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.